Technology | December 21, 2009

Vascular Graft Offers Radial Support, Thromboresistance


December 21, 2009 – The recently introduced GORE PROPATEN Vascular Graft has integrated rings that reduce the cross-sectional profile by 24 percent as compared to externally ringed grafts, and its radial reinforcement allows for improved blood flow. GORE introduced the new Vascular Graft at the 2009 AIMsymposium/VEITHsymposium in November in New York City. The grafts offer radial support that is concealed within the graft wall and resists kinking and compression. The stent graft also has a covalently-bonded PROPATEN Bioactive Surface to help prevent thrombus formation. The coating uses heparin on the luminal surface, which allows the graft to retain its thromboresistant bioactive properties over time. “Optimal graft performance in vascular surgery requires materials to be flexible to allow for smooth implantation,” said Michael Stoner, M.D., associate professor of vascular surgery for the East Carolina Heart Institute at East Carolina University, Greenville, N.C. “The new configurations of the GORE PROPATEN Vascular Graft with Integrated Rings will allow for easier placement through a tissue tunnel and enable clinicians to cut and sew through the radial support anywhere along the entire length of the graft. Based on experience to date, I am optimistic that this new feature will further help surgeons more effectively treat challenging cases and improve the outcomes of patients with vascular disease.” The manufacturer says the GORE PROPATEN Vascular Graft is the first vascular graft approved for hemodialysis access and the treatment of peripheral artery disease (PAD). For more information: www.goremedical.com

 


Related Content

News | Peripheral Artery Disease (PAD)

Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...

Home November 08, 2024
Home
News | Peripheral Artery Disease (PAD)

Sept. 16, 2024 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech, has announced the full U.S. launch of the ...

Home September 16, 2024
Home
News | Peripheral Artery Disease (PAD)

Sept. 1, 2024 — September is Peripheral Artery Disease (PAD) Awareness Month, a time to educate and empower people to ...

Home September 04, 2024
Home
News | Peripheral Artery Disease (PAD)

May 16, 2024 — Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care ...

Home May 16, 2024
Home
News | Peripheral Artery Disease (PAD)

May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...

Home May 08, 2024
Home
News | Peripheral Artery Disease (PAD)

March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...

Home March 20, 2024
Home
News | Peripheral Artery Disease (PAD)

February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...

Home February 12, 2024
Home
News | Peripheral Artery Disease (PAD)

November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for ...

Home November 10, 2023
Home
News | Peripheral Artery Disease (PAD)

October 24, 2023 — Four years ago, following a publication based on the limited data available, the U.S. Food and Drug ...

Home October 24, 2023
Home
News | Peripheral Artery Disease (PAD)

September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...

Home September 14, 2023
Home
Subscribe Now